Megafarma,an Azelis company,strengthens its presence for CASE in Mexico through distribution of BASF Monomers

WESTPORT, CT and MEXICO CITY – Megafarma, an Azelis company, is delighted to announce that it has been authorized by BASF Monomers, a global leader in the development, production and sales of polyurethanes- to distribute their polyurethane raw materials in Mexico. The exclusive distribution agreement includes BASF’s lines of Lupranate® isocyanates and Pluracol® polyols. The agreement is effective immediately.

Highlights & rationale

• This new mandate further strengthens Azelis’ strategic acquisition of Megafarma earlier this year to expand into the Latin American CASE market.
• It leverages existing Azelis Americas CASE assets, including application labs, digital platforms, technical and market intelligence, in the Mexican market.
• The mandate is in line with Azelis’ corporate strategy of organic growth through the expansion of existing relationships with key principals into new territories.

Martin Hernandez Gutiérrez, Director General at Megafarma, an Azelis company, comments:
“Megafarma has been very successful in life sciences in Mexico and the merger with Azelis earlier this year brought us new opportunities and enabled us to enter new market segments. This new agreement with BASF is the latest example of our commitment to expand into Mexican CASE sector and become a leading distributor with unsurpassed quality, logistics and technical support for our customers and principals.”

Dan Gruber, Managing Director, New Business Development, Azelis Americas CASE, says:
“We have a longstanding relationship with BASF. In the U.S and Canada we have demonstrated organic growth via our dedicated and technically trained sales force, and our application labs have been instrumental in our joint success. We are very excited about this expansion into the Mexican market as it allows us to deliver the same value and growth that we have provided BASF Polyurethanes in the U.S and Canada.”

Rachel Miller, CASE Distribution, Monomers, North America, BASF Corporation, says:
“This collaboration with Megafarma will provide our CASE specialties customers in Mexico with the service and expertise our U.S. customers are accustomed to. Our portfolio of Lupranate® isocyanates and Pluracol® polyols can be formulated to create a variety of specialty products now in Mexico.”

Lucia Zamudio, CASE Sales Director, Megafarma, an Azelis company, adds:
“We have built a team of excellent, experienced technical sales representatives for the CASE market who are ready to pursue new business opportunities for BASF. This latest portfolio addition is complementary to our other new CASE mandates for Mexico. We have confidence that we will bring the same high quality of technical sales and service to the Mexican Urethane Market.”

About BASF

BASF Corporation, headquartered in Florham Park, New Jersey, is the North American affiliate of BASF SE Ludwigshafen, Germany. BASF has more than 18,800 employees in North America and had sales of $18.4 billion in 2019. For more information about BASF’s North American operations, visit www.basf.com/us.

At BASF, we create chemistry for a sustainable future. We combine economic success with environmental protection and social responsibility. More than 117,000 employees in the BASF Group work on contributing to the success of our customers in nearly all sectors and almost every country in the world. Our portfolio is organized into six segments: Chemicals, Materials, Industrial Solutions, Surface Technologies, Nutrition & Care and Agricultural Solutions. BASF generated sales of €59 billion in 2019. BASF shares are traded on the stock exchange in Frankfurt (BAS) and as American Depositary Receipts (BASFY) in the U.S. Further information at https://www.basf.com.

About Azelis

Azelis is a leading distributor of specialty chemicals and food ingredients present in over 50 countries across the globe with around 2,200 employees. Our knowledgeable teams of industry, market and technical experts are each dedicated to a specific market within Life Sciences and Industrial Chemicals. We offer a lateral value chain of complementary products to about 40,000 customers, creating a turnover of $2.37 billion (2019). In the US we operate under a number of renowned co-brands that cater to the various markets in the region.

Throughout our extensive network of more than 60 application laboratories, our award-winning technical staff help customers develop formulations. We combine a global reach with a local focus to offer a reliable, integrated service to local customers and attractive business opportunities to principals. And we believe in building and nurturing solid, honest and transparent relationships with our people and partners.

Impact through ideas. Innovation through formulation.

www.azelis.com/americas

Contact information

Megafarma, an Azelis company, CASE Division
Lucia Zamudio
Sales Director
T: +(55) 5293 8797 (office)
E: lzamudio@megafarma.com.mx

Azelis Americas
Terry Mullin
Corporate Communications
T: 203 883 1477
E: terry.mullin@azelisamericas.com